Aug 12, 2021 10:00 PM IST
- Jul 14, 2021 11:01 PM IST
Abdul Azees sold 27.51 lakh equity shares in Uttam Galva Steels, Kredence Multi Trading sold 20 lakh shares and Glaxo Finance sold 10 lakh shares in the company at Rs 4.6 per share.
- Sep 15, 2020 04:06 PM IST
The shareholding of Max India sponsor group, which is not tendering its shares for capital reduction, is likely to increase to 51 percent from the current 41 percent, company said.
- Aug 28, 2020 03:52 PM IST
Max India resumed trading on BSE and NSE on August 28. The company, earlier known as Advaita Allied Health Services Limited, is a part of the $3-billion Max Group.
- Aug 27, 2020 02:24 PM IST
Max India, earlier known as Advaita Allied Health Services Limited, is a part of the $3 billio Max Group.
- Jun 15, 2020 03:08 PM IST
The company has already tied up with a landlord to develop this 4-acre project, located at Sector 150 in Noida, Uttar Pradesh.
- Jun 01, 2020 04:03 PM IST
"The demerger will enable Max India to focus on the high potential category of Senior Care," Analjit Singh of Max Group said.
- May 06, 2020 10:42 PM IST
Mumbai-headquartered Future, India’s largest retail firm, holds a 50 percent stake in Future Generali India Insurance, which commenced operations in 2007.
- Apr 05, 2020 02:40 PM IST
The promoters are obligated to hold a minimum 26 per cent shares and management control of Torrent Pharma during the period of loans the company has taken, it said.
- Apr 03, 2020 05:58 PM IST
In addition, the exchange has dropped six companies from surveillance action category for having higher levels of pledged shares by promoters.
- Dec 04, 2019 09:36 AM IST
The all-cash transaction announced in February 2019 valued Max Bupa at an enterprise value of Rs 1001 crore.
- Dec 03, 2019 12:49 PM IST
On February 26, 2019, Max India had informed the stock exchange regarding the proposal for divestment of entire shareholding of the company in Max Bupa Health Insurance Company.
- Aug 08, 2019 06:17 PM IST
- Jun 24, 2019 01:10 PM IST
Max India owns and actively manages a 49.70 percent stake in Max Healthcare, a 51 percent stake in Max Bupa Health Insurance and a 100 percent stake in Antara Senior Living
- Feb 26, 2019 02:27 PM IST
Max Bupa Health Insurance Company is a joint venture between Max India with 51 percent stake and the UK based healthcare services expert, Bupa with 49 percent stake.
- Feb 11, 2019 04:13 PM IST
- Dec 26, 2018 04:00 PM IST
The owner’s decision to exit seems to be a mixture of personal and business reasons. But the regulatory risks in the business have played a bigger role in the decision, for certain.
- Dec 24, 2018 03:08 PM IST
The deal includes Radiant Life's purchase of a 49.7 percent stake in Max Healthcare from South Africa-based hospital operator Life Healthcare International Proprietary.
- Dec 14, 2018 02:49 PM IST
The breadth of the market favoured the advances with 764 stocks advancing and 913 declining while 384 remained unchanged. On the BSE, 1157 stocks advanced, 1297 declined and 142 remained unchanged.
- Nov 02, 2018 04:38 PM IST
- Oct 12, 2018 12:42 PM IST
The company in its disclosure filed with the exchange said it has pledged additional 2.04 percent stake with Bajaj Finance.
- Apr 09, 2018 04:03 PM IST
In February this year, Max India had informed stock exchanges that Life Healthcare Group Holdings had initiated preliminary discussions with it to explore the possibility of acquisition of the South Africans firm's shares in Max Healthcare Institute.
- Apr 07, 2018 08:47 PM IST
Max India said it’s early days to talk about company buying out partner Life Healthcare Group’s 47.5 percent stake in Max Healthcare as the valuation process is still underway.
- Jan 09, 2018 10:12 AM IST
The market breadth was in favour of the declines on Tuesday morning with 780 stocks advancing as against 844 declines while 378 remained unchanged. On the other hand, 1222 stocks advanced and 1149 stocks declined while 76 remained unchanged on the BSE.
- Nov 03, 2017 04:44 PM IST
Edelweiss is bullish on Max India has recommended buy rating on the stock with a target price of Rs 170 in its research report dated November 02, 2017.